Development of brain metastases in non-small-cell lung cancer: high-risk features

Development of brain metastases in non-small-cell lung cancer: high-risk features

Aim: Brain metastases (BM) are a common site of disease progression and treatment failure in non-small-cell lung cancer (NSCLC) and can be identified in up to 30–50% of patients. Although they are common, there is no standardized screening protocol for development of BM in NSCLC. Multiple clinical v...

Full description

Saved in:
Bibliographic Details
Main Authors: Nolan Winslow, Jacqueline Boyle, William Miller, Yanzhi Wang, Francois Geoffroy, Andrew J Tsung
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:CNS Oncology
Subjects:
brain metastases
lung cancer
MRI
non-small-cell lung cancer
screening
Online Access:https://www.tandfonline.com/doi/10.1080/20450907.2024.2395804
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items